Dopamine Receptor Availability in ADHD
Striatal dopamine (D2) receptor availability was determined by iodobenzamide brain SPECT, before and 3 months after methylphenidate (MPH) therapy, in 9 children (mean age, 9.8 years) with attention deficit hyperactivity disorder (ADHD) examined at Gazi University, Ankara, Turkey.
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Pediatric Neurology Briefs Publishers,
2002-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_69de9f70c5b64a8a8f1cbcbbdea25499 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a J Gordon Millichap |e author |
| 245 | 0 | 0 | |a Dopamine Receptor Availability in ADHD |
| 260 | |b Pediatric Neurology Briefs Publishers, |c 2002-01-01T00:00:00Z. | ||
| 500 | |a 1043-3155 | ||
| 500 | |a 2166-6482 | ||
| 500 | |a 10.15844/pedneurbriefs-16-1-10 | ||
| 520 | |a Striatal dopamine (D2) receptor availability was determined by iodobenzamide brain SPECT, before and 3 months after methylphenidate (MPH) therapy, in 9 children (mean age, 9.8 years) with attention deficit hyperactivity disorder (ADHD) examined at Gazi University, Ankara, Turkey. | ||
| 546 | |a EN | ||
| 690 | |a striatal dopamine | ||
| 690 | |a methylphenidate | ||
| 690 | |a attention deficit hyperactivity disorder | ||
| 690 | |a Pediatrics | ||
| 690 | |a RJ1-570 | ||
| 690 | |a Neurology. Diseases of the nervous system | ||
| 690 | |a RC346-429 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pediatric Neurology Briefs, Vol 16, Iss 1, Pp 7-7 (2002) | |
| 787 | 0 | |n https://www.pediatricneurologybriefs.com/articles/1679 | |
| 787 | 0 | |n https://doaj.org/toc/1043-3155 | |
| 787 | 0 | |n https://doaj.org/toc/2166-6482 | |
| 856 | 4 | 1 | |u https://doaj.org/article/69de9f70c5b64a8a8f1cbcbbdea25499 |z Connect to this object online. |